Emerging Pathologies in Cardiology

1. Pathogenetic and Immunological Paradigm of Atherosclerotic Plaque
G. Calcara, C. Corno

2. Are a Single Measurement of Troponin-I and C-Reactive Protein of Clinical Significance in Patients with Acute Coronary Syndromes?
L. Oltrona, R. Pirola

3. New Strategies for Treating Myocardial Infarctions
F. Chiarella, A. Nicolino, K. Paonessa, F. Rossi

4. Tirofiban and NSTE-ACS: The Current Perspective
C. Cavallini

5. Acute Coronary Syndromes and Diabetes: How Much Can We Intervene?
F. Bovenzi, L. Luca, R. Adorisio

6. Spinal Cord Stimulation in Refractory Coronary Artery Disease: The Last Resort?
H. Theres, S. Eddicks, M. Schenk, K. Maier-Hauff, C. Spies, G. Baumann

7. Guidelines for Antihypertensive Treatment: The Debate on the Choice of Antihypertensive Drugs
A. Salvetti, L. Ghiadoni, G. Salvetti

8. Aspirin and Cardiovascular Prevention in the Guidelines and in the Real World
G. Pasquale, P.C. Pavesi, G. Casella

9. Serial Changes in Left Ventricular Mass in Hypertension: Prognostic Impact
P. Verdecchia, F. Angeli, M.G. Sardone, R. Gattobigio

10. New Approach in the Prevention of Atrial Fibrillation: Role of Angiotensin II Antagonists
P. Verdecchia, F. Angeli, M. G. Sardone, R. Gattobigio

11. Role of Echocardiography in the Management of Atrial Fibrillation Patients
F. Antonini-Canterin, G. Allocca, D. Rivaben, R. Korcova-Miertusova, R. Piazza, M. Brieda, E. Hrovatin, E. Dametto, F. Zardo, G.L. Nicolosi

12. Pharmacological Prevention of Arrhythmic Recurrences
G. Chiaranda, M.L. Cavarra, C.L. Romeo, M. Chiaranda, T. Regolo

13. Timing and Typology of Cardio-Embolic Prevention in Patients with Atrial Fibrillation
G. Pasquale, G. Casella, P.C. Pavesi

14. Non-Electric Treatment of Atrial Fibrillation: When Not to Treat?
R.F.E. Pedretti

15. The Role of Imaging in Catheter Ablation of Atrial Fibrillation
J. Kautzner, P. Peichl, H. Mlcochova

16. Atypical Atrial Flutter
A.S. Montenero

17. Advances in Surgical Treatment of Atrial Fibrillation
L. Patanè, A. Cavallaro

18. Guidelines for the Management of Patients with Heart Failure
G. Sinagra, G. Sabbadini, S. Rakar, A. Perkan, M. Zecchin, L. Salvatore, F. Longaro, A. Lenarda

19. How to Detect Dyssynchrony and How to Correct It
L. Ascione, M. Accadia, R. Iengo, S.E. Rumolo, C. Muto, M. Canciello, G. Carreras, B. Tuccillo

20. Advancements in ‘Over-the-Wire” Versus Stylet-Guided Left Ventricular Leads
S. Boveda

21. Assessment of Diastolic Function in Heart Failure and Atrial Fibrillation
S. Carerj, S. Raffa, C. Zito

22. Is CRT Useful in Patients with Atrial Fibrillation?
l. Paperini, M. Carluccio, E. Pardini

23. Future New Indications for CRT: Which Patients Might Benefit?
B. Pezzulich, P. Greco Lucchina

24. Economic Benefits of Cardiac Resynchronisation Therapy
K. Seidl

25. Cost-Effectiveness of Cardiac Resynchronisation Therapy in Heart Failure Patients
G. Mascioli, A. Curnis, L. Bontempi, T. Bordonali, L. Dei Cas

26. Guidelines for the Prevention of Sudden Cardiac Death: Filling the Gap
A. Baranchuk, C. Morillo

27. Management of Cardiac Arrhythmias in Post-PCI Patients
B. Gorenek

28. Anti-tachycardia Pacing for Termination of Rapid Ventricular Tachycardia in Patients with Implantable Cardioverter-Defibrillators. The PITAGORA ICD Trial
M. Gulizia, S. Mangiameli, F. Mascia, V.A. Ciconte, R.M. Polimeni, A. Capucci, V. Calogero, C. Puntrello, S. Sammartano, M. Scherillo, O. Pensabene, M.C. Scianaro

29. MADIT II/SCD-HeFT Results: Have They Already Achieved an Impact in Europe?
A. Arenal, M. Ortiz

30. Short QT: The Novel Gaita Syndrome?
F. Gaita, C. Giustetto, F. Monte, R. Schimpf, C. Wolpert, M. Borggrefe

31. Remote Patient Management of ICD: Of What Value Is It in Clinical Practice?
S. Sermasi, M. Marconi, M. Mezzetti, G. Piovaccari

32. BLSD Prevention of Sudden Death: What Is the Difference Between Lay People and Medical Professionals?
M. Santomauro, N. Monteforte, C. Riganti, E. Febbraro, C. Liguori, A. Costanzo, L. D’Agostino Di Salvatore, A. Casafina, M. Chiariello

33. ACC/ESC Recommendations for the Clinical Management of Hypertrophic Cardiomyopathy: A Practical Perspective
P. Delise, M. Bocchino, L. Sciarra, E. Marras, N. Sitta, L. Coro’, E. Moro

34. Risk Identification in Arrhythmic Athletes with Fatal or Resuscitated Cardiac Arrest
F. Furlanello, A. Bertoldi, C. Furlanello, G. Galanti, P. Manetti, F. Fernando, F. Terrasi, M. Dallago, L. Gramegna, M. Barbareschi, A. Biffi, G. Vergara, G. Inama, G. Butera, C. Esposito, M. Marangoni, G. Thiene, R. Cappato

35. Physiological Pacing: Perspective
I.E. Ovsyshcher

36. Optimal Pacing Site in the Atrium and the Ventricle for Patients with Sino-Atrial Disease
G. Senatore, C. Amellone, G. Donnici, B. Giordano, G. Trapani, J.I. Rocanova, M. Fazzari

37. Role of His-Bundle Pacing: Reliability and Potential to Avoid Ventricular Dyssynchrony
F. Zanon, E. Baracca, S. Aggio, G. Boaretto, G. Pastore, P. Zonzin

38. Pacemaker for Vasovagal Syncope: Good for the Few
M. Brignole

39. Quality of Life of Patients with an Atrial Defibrillator: Does Optimal Programming Achieve the Goal of Maintaining Sinus Rhythm as Well as Improve Quality of Life?
A. Quesada, V. Palanca, J. Jimenez, O. Villalba, R. Paya, J.R. Balaguer, S. Illalba, J. Roda

40. Haemodynamic Assessment by Transvalvular Impedance Recording
M.G. Bongiorni, E. Soldati, G. Arena, G. Giannola, C. Bartoli, A. Barbetta, F. Gregorio

41. Rate-Responsive Pacing Controlled by Transvalvular Impedance: Preliminary Clinical Experience
E. Occhetta, G. Gasparini, A. Curnis, M. Gulizia, M. Bortnik, A. Magnani, A. Corrado, L. Bontempi, G. Mascioli, G.M. Francese, F. Gregorio, A. Barbetta, A. Raviele

42. Initial Experience of Implanted Pacemakers with Intracardiac Haemodynamic Sensor: Evaluation of Sensor Safety
N. Galizio, J. Gonzalez, R. Chirife, H. Fraguas, J. Barra, S. Graf, E. Forteza, F. Gregorio

43. Transvalvular Impedance in the Autoregulation of a Cardiac Pacemaker
F. Dorticós, M.A. QuiÑones, F. Tornes, Y. Fayad, R. Zayas, J. Castro, A. Barbetta, F. Gregorio

44. Guidelines for the Management of Syncope
M. Brignole

45. Role of Anamnesis: Is It a Complete Tool?
P. Alboni, M. Dinelli, F. Pacchioni

46. Is There Still a Role for Drug Therapy in Vasovagal Syncope?
M. Gulizia, G.M. Francese

47. When Do We Need a Permanent Pacemaker in Neuromediated Syncope?
F. Giada, A. Raviele

48. CT Coronary Angiography with 16-Row Multi-slice Scanner: Do We Still Need Conventional Coronary Angiography?
F. Cademartiri, G. Runza, M. Belgrano, P. Malagutti, N. Mollet, P. Feyter

49. Multislice CT for the Study of Aortic Aneurysms
V. Magnano San Lio, E.M. Maggio

50. MRI in the Diagnosis of Right Ventricular Dysplasia
M. Midiri, M. Galia, T.V. Bartolotta

DRM-restrictions

Printing: not available
Clipboard copying: not available

Nyckelord: MEDICAL / Public Health MED078000